Sanuwave receives $5M cash from option exercise for patent sale

SANUWAVE Health, Inc.

Licensee exercised option on August 21, 2025, to acquire patents for intravascular shockwave applications.
Sanuwave received a $5.0M cash payment in connection with the option exercise.
Previously, the Licensee paid $2.5M for an exclusive license and the option in March 2024.
The patents are related to the field of intravascular shockwave applications.
No additional ongoing obligations from Sanuwave are disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.